Area of research
Radiology, Nuclear Medicine and Imaging · Oncology
Research interest
Research interests include HER2/EGFR in Cancer Research, Glioma Diagnosis and Treatment, Radiopharmaceutical Chemistry and Applications, and Cancer, Hypoxia, and Metabolism.
Author Correction: Dose escalation and expansion cohorts in patients with advanced breast cancer in a Phase I study of the CDK7-inhibitor samuraciclib
Dose escalation and expansion cohorts in patients with advanced breast cancer in a Phase I study of the CDK7-inhibitor samuraciclib
379MO Datopotamab deruxtecan (Dato-DXd) + durvalumab (D) as first-line (1L) treatment for unresectable locally advanced/metastatic triple-negative breast cancer (a/mTNBC): Updated results from BEGONIA, a phase Ib/II study
Author Correction: Dose escalation and expansion cohorts in patients with advanced breast cancer in a Phase I study of the CDK7-inhibitor samuraciclib
Phase 1b study of berzosertib and cisplatin in patients with advanced triple-negative breast cancer
Trastuzumab duocarmazine in locally advanced and metastatic solid tumours and HER2-expressing breast cancer: a phase 1 dose-escalation and dose-expansion study
Hypoxia-induced switch in SNAT2/SLC38A2 regulation generates endocrine resistance in breast cancer
Imaging tumour hypoxia with positron emission tomography